<DOC>
	<DOCNO>NCT02261948</DOCNO>
	<brief_summary>The present study conceive evaluate effect levosimendan cardiopulmonary exercise test ( CPET ) DLCO ( Diffusion capacity Lung carbon monoxide ) patient severe heart failure stable clinical condition ( NYHA - New York Heart Association - class III , peak VO2 ( Oxygen consumption ) &lt; 12 ml/min/kg ) top optimize standard therapy .</brief_summary>
	<brief_title>Levosimendan Efficacy Assessment Cardiopulmonary Exercise Test ( CPET )</brief_title>
	<detailed_description>Eligible patient chronic HF ( Heart Failure -class NYHA III IV ) stable clinical condition . Inclusion criterion : leave ejection fraction ( EF ) echocardiography ≤35 % , age ≥18 year old , peak VO2 &lt; 12 ml/min/kg measure CPET , standard optimize therapy HF include ACE-inhibitors , ARBs ( angiotensin II Receptor Blocker ) , aldosterone block agent ( spironolactone ) , diuretic , beta-blockers . The exclusion criterion : ongoing mechanical ventilation ; recent acute coronary syndrome ; sustain ventricular tachycardia ventricular fibrillation ; severe aortic mitral regurgitation , know malfunction artificial heart valve ; uncorrected obstructive valvular disease ; hypertrophic obstructive cardiomyopathy ; uncorrected thyroid disease . Patients randomly assign mean prepared letter levosimendan placebo group stratify clinical centre 1:1 allocation use block randomization . The placebo infusion colour identically respective active counterpart . Patients investigator keep blinded treatment allocation entire duration trial . Study drug infuse injection speed 6 20 ml/min base blood pressure , without bolus , 24 hour . Medical history , physical examination blood sample examination record : NYHA class , BNP ( Brain Natriuretic Peptide ) , haemoglobin , creatinine , blood urea nitrogen ( BUN ) record 24 hour drug infusion . A two-dimensional standard echocardiography evaluation perform admission hospital . A maximal CPET perform cycle ergometer ( Sensor Medics Ergo 800S V-max , Yorba-Linda , CA ) personalize ramp aim achieve peak exercise 10 minute perform 24 hour drug infusion . Expiratory O2 , CO2 ( Carbon dioxide ) ventilation ( VE ) measure breath breath . Peak VO2 ( Carbon dioxide production ) consider high VO2 achieve exercise . A 12-lead electrocardiogram also record . Spirometry DLCO measurement perform ad 24-hours drug infusion . . DLCO measure single breath-constant expiratory flow technique</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>inform consent study sign severe heart failure stable clinical condition ( NYHA class III , peak VO2 &lt; 12 ml / kg / min ) optimize medical therapy . The clinical stability define stability therapy , weight urine output 3 day unstable patient clinical point view , optimize therapy patient unable perform CPET ( Cardiopulmonary Exercise Test ) . exclude protocol also patient absolute contraindication CPET ( acute myocardial infarction , severe aortic stenosis , myocarditis pericarditis , active , acute thromboembolism , sepsis , unstable angina , uncontrolled arrhythmia . age &lt; 18 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cardiac Failure</keyword>
	<keyword>Severe Heart Failure</keyword>
</DOC>